49 related articles for article (PubMed ID: 8206485)
1. Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas.
Shukla ND; Schroers-Martin JG; Sworder BJ; Kathuria KR; Alig SK; Frank MJ; Miklos DB; Coutre S; Diehn M; Khodadoust MS; Roschewski M; Kurtz DM; Alizadeh AA
Blood Adv; 2024 Feb; 8(3):780-784. PubMed ID: 38147627
[No Abstract] [Full Text] [Related]
2. Therapy of non-Hodgkin's lymphoma.
Coffey J; Hodgson DC; Gospodarowicz MK
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S28-36. PubMed ID: 12692688
[TBL] [Abstract][Full Text] [Related]
3. Gene amplification of Japanese non-Hodgkin lymphoma with involvement of the BCL2 gene.
Miyamura K; Kobayashi T; Sasaki T; Ibuka T; Imai K; Sakai Y; Kawaguchi K; Miyashita T; Iwaya M; Mizutani S
Int J Hematol; 1991 Apr; 54(2):137-40. PubMed ID: 1747446
[TBL] [Abstract][Full Text] [Related]
4. [Cytogenetic and molecular aspects in MALT lymphomas].
Robledo M; Santos M; Santón A; Echezarreta G; Rivas C; Benítez J
Sangre (Barc); 1991 Aug; 36(4):295-9. PubMed ID: 1776108
[TBL] [Abstract][Full Text] [Related]
5. The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
Galimberti S; Marasca R; Caracciolo F; Fazzi R; Papineschi F; Benedetti E; Guerrini F; Morabito F; Oliva E; Di Renzo N; Federico M; Petrini M; Torelli G;
Bone Marrow Transplant; 2002 Apr; 29(7):581-7. PubMed ID: 11979307
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of residual disease in non-Hodgkin's lymphomas by quantitative PCR (preliminary report).
Slavícková A; Ullmannová V; Benesová E; Klener P
Folia Biol (Praha); 1999; 45(5):179-83. PubMed ID: 10730886
[TBL] [Abstract][Full Text] [Related]
7. Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction.
Gribben JG; Nadler LM
Important Adv Oncol; 1994; ():117-29. PubMed ID: 8206485
[No Abstract] [Full Text] [Related]
8. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
Larsen CJ; Mecucci C; Leroux D
Nouv Rev Fr Hematol (1978); 1990; 32(6):401-3. PubMed ID: 2129304
[TBL] [Abstract][Full Text] [Related]
9. The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders.
Pezzella F; Mason DY
Nouv Rev Fr Hematol (1978); 1990; 32(6):397-9. PubMed ID: 2101872
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
Gaidano G; Pastore C; Volpe G
Haematologica; 1995; 80(5):454-72. PubMed ID: 8566891
[TBL] [Abstract][Full Text] [Related]
11. BCL-2 gene rearrangements in lymphoid malignancies.
Crisan D
Clin Lab Med; 1996 Mar; 16(1):23-47. PubMed ID: 8867581
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
